Eco Animal Health Group Plc

Research Eco Animal Health Group Plc (EAH) on Bullrun: market cap GBX 6.54B, P/E 32.7. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is GBX 6.54B; P/E is 32.7.

Peer valuation comparison

Latest P/E is 32.67x versus a Healthcare sector median of 24.6x (32.8% above).

Latest P/E is 32.67x versus a United Kingdom median of 15.22x (114.6% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025GBP 79.60MGBP 1.69MGBP 5.44M45.1%0.02GBP 25.01MGBP 3.79MGBP 85.50M
FY2024GBP 89.42MGBP 1.05MGBP 4.79M42.1%0.02GBP 22.37MGBP 4.03MGBP 83.69M
FY2023GBP 85.31MGBP 1.01MGBP 9.93M45.0%0.01GBP 21.66MGBP 4.48MGBP 83.27M
FY2022GBP 82.20M-GBP 686.00K-GBP 3.44M42.7%-0.01GBP 14.31MGBP 1.91MGBP 82.06M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-09-28GBX 6.54B32.7n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 GBX.

YearDividends/share
FY20230.28 GBP
FY20220.47 GBP

About Eco Animal Health Group Plc

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers Ecomectin to treat parasites in cattle, sheep, and pigs; and ECOVAXXIN MS, a mycoplasma solution. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Eco Animal Health Group Plc's market cap?

Eco Animal Health Group Plc's market capitalization is GBX 6.54B.

What is Eco Animal Health Group Plc's P/E ratio?

Eco Animal Health Group Plc's price-to-earnings (P/E) ratio is 32.7.

What does Eco Animal Health Group Plc do?

ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers Ecomectin to treat parasites in cattle, sheep, and pigs; and ECOVAXXIN MS, a mycoplasma solution. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.